BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 17611268)

  • 1. Rab5 mediates an amyloid precursor protein signaling pathway that leads to apoptosis.
    Laifenfeld D; Patzek LJ; McPhie DL; Chen Y; Levites Y; Cataldo AM; Neve RL
    J Neurosci; 2007 Jul; 27(27):7141-53. PubMed ID: 17611268
    [TBL] [Abstract][Full Text] [Related]  

  • 2. DNA synthesis and neuronal apoptosis caused by familial Alzheimer disease mutants of the amyloid precursor protein are mediated by the p21 activated kinase PAK3.
    McPhie DL; Coopersmith R; Hines-Peralta A; Chen Y; Ivins KJ; Manly SP; Kozlowski MR; Neve KA; Neve RL
    J Neurosci; 2003 Jul; 23(17):6914-27. PubMed ID: 12890786
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evidence that the rab5 effector APPL1 mediates APP-βCTF-induced dysfunction of endosomes in Down syndrome and Alzheimer's disease.
    Kim S; Sato Y; Mohan PS; Peterhoff C; Pensalfini A; Rigoglioso A; Jiang Y; Nixon RA
    Mol Psychiatry; 2016 May; 21(5):707-16. PubMed ID: 26194181
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Amyloid precursor protein-mediated endocytic pathway disruption induces axonal dysfunction and neurodegeneration.
    Xu W; Weissmiller AM; White JA; Fang F; Wang X; Wu Y; Pearn ML; Zhao X; Sawa M; Chen S; Gunawardena S; Ding J; Mobley WC; Wu C
    J Clin Invest; 2016 May; 126(5):1815-33. PubMed ID: 27064279
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Endocytic pathway abnormalities precede amyloid beta deposition in sporadic Alzheimer's disease and Down syndrome: differential effects of APOE genotype and presenilin mutations.
    Cataldo AM; Peterhoff CM; Troncoso JC; Gomez-Isla T; Hyman BT; Nixon RA
    Am J Pathol; 2000 Jul; 157(1):277-86. PubMed ID: 10880397
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rab5-stimulated up-regulation of the endocytic pathway increases intracellular beta-cleaved amyloid precursor protein carboxyl-terminal fragment levels and Abeta production.
    Grbovic OM; Mathews PM; Jiang Y; Schmidt SD; Dinakar R; Summers-Terio NB; Ceresa BP; Nixon RA; Cataldo AM
    J Biol Chem; 2003 Aug; 278(33):31261-8. PubMed ID: 12761223
    [TBL] [Abstract][Full Text] [Related]  

  • 7. beta-Secretase cleavage of the amyloid precursor protein mediates neuronal apoptosis caused by familial Alzheimer's disease mutations.
    McPhie DL; Golde T; Eckman CB; Yager D; Brant JB; Neve RL
    Brain Res Mol Brain Res; 2001 Dec; 97(1):103-13. PubMed ID: 11744168
    [TBL] [Abstract][Full Text] [Related]  

  • 8. APP-BP1 mediates APP-induced apoptosis and DNA synthesis and is increased in Alzheimer's disease brain.
    Chen Y; Liu W; McPhie DL; Hassinger L; Neve RL
    J Cell Biol; 2003 Oct; 163(1):27-33. PubMed ID: 14557245
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clathrin-dependent APP endocytosis and Abeta secretion are highly sensitive to the level of plasma membrane cholesterol.
    Cossec JC; Simon A; Marquer C; Moldrich RX; Leterrier C; Rossier J; Duyckaerts C; Lenkei Z; Potier MC
    Biochim Biophys Acta; 2010 Aug; 1801(8):846-52. PubMed ID: 20580937
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-apoptotic wild-type Alzheimer amyloid precursor protein signaling involves the p38 mitogen-activated protein kinase/MEF2 pathway.
    Burton TR; Dibrov A; Kashour T; Amara FM
    Brain Res Mol Brain Res; 2002 Dec; 108(1-2):102-20. PubMed ID: 12480183
    [TBL] [Abstract][Full Text] [Related]  

  • 11. APP/Go protein Gβγ-complex signaling mediates Aβ degeneration and cognitive impairment in Alzheimer's disease models.
    Bignante EA; Ponce NE; Heredia F; Musso J; Krawczyk MC; Millán J; Pigino GF; Inestrosa NC; Boccia MM; Lorenzo A
    Neurobiol Aging; 2018 Apr; 64():44-57. PubMed ID: 29331876
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Late Simian virus 40 transcription factor is a target of the phosphoinositide 3-kinase/Akt pathway in anti-apoptotic Alzheimer's amyloid precursor protein signalling.
    Kashour T; Burton T; Dibrov A; Amara FM
    Biochem J; 2003 Mar; 370(Pt 3):1063-75. PubMed ID: 12472467
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A mutation protective against Alzheimer's disease renders amyloid β precursor protein incapable of mediating neurotoxicity.
    Hashimoto Y; Matsuoka M
    J Neurochem; 2014 Jul; 130(2):291-300. PubMed ID: 24646423
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The enhancement of amyloid precursor protein and beta-site amyloid cleavage enzyme 1 interaction: amyloid-beta production with aging.
    Zou L; Yang R; Zhang P; Dai Y
    Int J Mol Med; 2010 Mar; 25(3):401-7. PubMed ID: 20127045
    [TBL] [Abstract][Full Text] [Related]  

  • 15. App gene dosage modulates endosomal abnormalities of Alzheimer's disease in a segmental trisomy 16 mouse model of down syndrome.
    Cataldo AM; Petanceska S; Peterhoff CM; Terio NB; Epstein CJ; Villar A; Carlson EJ; Staufenbiel M; Nixon RA
    J Neurosci; 2003 Jul; 23(17):6788-92. PubMed ID: 12890772
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Rab5 activator RME-6 is required for amyloid precursor protein endocytosis depending on the YTSI motif.
    Eggert S; Gruebl T; Rajender R; Rupp C; Sander B; Heesch A; Zimmermann M; Hoepfner S; Zentgraf H; Kins S
    Cell Mol Life Sci; 2020 Dec; 77(24):5223-5242. PubMed ID: 32065241
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Drosophila amyloid precursor protein homologue mediates neuronal survival and neuroglial interactions.
    Kessissoglou IA; Langui D; Hasan A; Maral M; Dutta SB; Hiesinger PR; Hassan BA
    PLoS Biol; 2020 Dec; 18(12):e3000703. PubMed ID: 33290404
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Upregulation of RIN3 induces endosomal dysfunction in Alzheimer's disease.
    Shen R; Zhao X; He L; Ding Y; Xu W; Lin S; Fang S; Yang W; Sung K; Spencer B; Rissman RA; Lei M; Ding J; Wu C
    Transl Neurodegener; 2020 Jun; 9(1):26. PubMed ID: 32552912
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intracellularly generated amyloid-beta peptide counteracts the antiapoptotic function of its precursor protein and primes proapoptotic pathways for activation by other insults in neuroblastoma cells.
    Esposito L; Gan L; Yu GQ; Essrich C; Mucke L
    J Neurochem; 2004 Dec; 91(6):1260-74. PubMed ID: 15584903
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alzheimer's disease: a dysfunction of the amyloid precursor protein(1).
    Neve RL; McPhie DL; Chen Y
    Brain Res; 2000 Dec; 886(1-2):54-66. PubMed ID: 11119687
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.